Summary
The available techniques for the investigation of drug binding to plasma and tissues protein are reviewed and the advantages and disadvantages of the various techniques stated. A comparison of different plasma protein binding techniques is made which shows that the size of the unbound fraction of drug may be influenced by the method used. Protein binding may be assayed by methods including equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration, binding to albumin microspheres and circular dichroism. Tissue binding techniques can involve testing binding to isolated organs, tissue slices, homogenates and isolated subcellular particles. Details of the available methods to compute pharmacokinetic constants are given. Stereoselective binding has been investigated for a limited number of drugs and the difference in the binding of 2 enantiomers is usually modest. The measurement of the binding constants is often required to characterise the drug-protein interaction. Mathematical and graphical methods to compute the pharmacokinetic parameters are discussed. The implications of binding on the volume of distribution and clearance of drugs are examined.
Similar content being viewed by others
References
Aarons L, Grennan DM, Siddiqui M. The binding of ibuprofen to plasma proteins. European Journal of Clinical Pharmacology 25: 815–818, 1983
Albani F, Riva R, Contini M, Baruzzi A. Stereoselective binding of propranolol enantiomers to human alpha-acid glycoprotein and human plasma. British Journal of Clinical Pharmacology 18: 244–246, 1984
Anderson JH, Anderson RC, Iben LS. Hepatic uptake of propranolol. Journal of Pharmacology and Experimental Therapeutics 206: 172–180, 1978
Anderson MW, Orton TC, Pickett RD, Eling TE. Accumulation of amines in the isolated perfused rabbit lung. Journal of Pharmacology and Experimental Therapeutics 189: 456–466, 1974
Anderson NG. Analytical techniques for all cell fractions. Analytical Biochemistry 23: 72–83, 1968
Andreasen F. Protein binding of drugs in plasma from patients with acute renal failure. Acta Pharmacologica et Toxicologica 32: 417–429, 1973
Andreasen F, Christiansen EH. The influence of protein binding on vasoactivity. In Belpaire et al. (Eds) Plasma binding of drugs and its consequences, pp. 191–205, Academia Press, Ghent, 1990
Angevine LS, Mehendale HM. Chlorphentermine uptake by isolated perfused rabbit lung. Toxicology and Applied Pharmacology 52: 336–346, 1980
Anon. Graph Pad InPlot version 3.1 Graph PAD Software. San Diego USA 1990
Bachmann KA. Rapid determination of the concentration of unbound warfarin in human plasma. Research Communications in Chemical Pathology and Pharmacology 9: 379–382, 1974
Bahr C, Borga O. Uptake, metabolism and excretion of desmethylimipramine and its metabolites in the isolated perfused rat liver. Acta Pharmacologica et Toxicologica 29: 359–374, 1971
Balk L, Maner S, Bergstrand A, Birberg W, Pilotti A, De Pierre JW. Preparation and characterisation of subcellular fractions from the head kidney of the northern pike (esox lucius), with particular emphasis on xenobiotic-metabolising enzymes. Biochemical Pharmacology 34: 789–802, 1985
Barr J, Weier AJ, Brendel K, Sipes IG. Liver slices in dynamic organ culture II: an in vitro cellular technique for the study of integrated drug metabolism using human tissue. Xenobiotica 21: 341–50, 1991
Barry M, Keeling PWN, Weir D, Feely J. Severity of cirrhosis and the relationship of alpha-1-acid glycoprotein concentration to plasma protein binding of lidocaine. Clinical Pharmacology and Therapeutics 47: 366–370, 1990
Beeler TJ, Schibeci A, Martonosi A. The binding of arsenazo III to cell components. Biochimica et Biophisica Acta 629: 317–327, 1980
Berezney R, Macaulay LK, Crane FL. The purification and biochemical characterisation of bovine liver nuclear membranes. Journal of Biological Chemistry 247: 5549–5561, 1972
Bergstrand A, Dallner G. Isolation of rough and smooth microsomes from rat liver by means of a commercially available centrifuge. Analytical Biochemistry 29: 351–356, 1969
Bertilsson L, Braithwaite R, Tybring G, Garle M, Borga O. Techniques for plasma protein binding of demethylchlorimipramine. Clinical Pharmacology and Therapeutics 26: 265–271, 1979
Bickel MH, Gigon PL. Intracellular binding and metabolism of imipramine and imipramine-N-oxide. Chemico-Biological Interactions 3: 245–246, 1971
Bickel MH, Raaflaub RM, Hellmuller M, Stauffer EJ. Characterization of drug distribution and binding competition by two-chamber and multi-chamber distribution dialysis. Journal of Pharmaceutical Sciences 76: 68–74, 1987
Blanck TJJ, Gillis CN. β-Adrenergic receptor ligand binding by rabbit lung. Biochemical Pharmacology 28: 1903–1909, 1979
Blaschke TF. Protein binding and kinetics of drugs in liver diseases. Clinical Pharmacokinetics 2: 32–44, 1977
Borga O, Odar-Cedelof I, Ringberger VA, Norlin A. Protein binding of salicylate in uremic and normal plasma. Clinical Pharmacology and Therapeutics 20: 464–475, 1976
Branch RA, Jones J, Read AE. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. British Journal of Clinical Pharmacology 3: 243–249, 1976
Breeding M. Scatchard analysis program by Biosoft, Cambridge UK 1987
Brodersen R, Sjodin T, Sjoholm I. Independent binding of ligands to human serum albumin. Journal of Biological Chemistry 252: 5067–5072, 1977
Brors O, Sager G, Sandnes D, Jacobsen S. Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. British Journal of Clinical Pharmacology 15: 393–397, 1983
Buch H, Knabe J, Buzello W, Rummel W. Stereospecificity of anesthetic activity distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. Journal of Pharmacology and Experimental Therapeutics 175: 709–716, 1970
Cerletti C, Coccia P, Manara L, Mennini T. Subcellular distribution of etorphine in rat brain and evidence for in vivo stereospecific binding. British Journal of Pharmacology 62: 31–38, 1978
Chau KH, Yang JT. Comparison of circular dichrometers: normal and difference circular dichroism measurements. Analytical Biochemistry 46: 616–623, 1972
Chignell CF. Circular dichroism studies of drug-protein complexes. Life Sciences 7: 1181–1186, 1968
Chignell CF. Optical studies of drug-protein complexes III: interaction of flufenamic acid and other N-arylanthranilates with serum albumin. Molecular Pharmacology 5: 455–462, 1969
Chignell CF. Optical studies of drug-protein complexes IV: the interaction of warfarin and dicoumarol with human serum albumin. Molecular Pharmacology 6: 1–12, 1970
Choie DD, Del Campo AA, Guarino AM. Subcellular localization of cis-dichlorodiammineplatinum (II) in rat kidney and liver. Toxicology and Applied Pharmacology 55: 245–252, 1980
Christensen JH, Andreasen F, Jensen EB. The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis. Acta Pharmacologica et toxicologica 47: 24–32, 1980
Colangelo P, Chandler M, Blouin R, McNamara P. Stereoselective binding of propranolol in the elderly. British Journal of Clinical Pharmacology 27: 519–522, 1989
Colburn RW, Ng LKY, Lemberger L, Kopin I. Subcellular distribution of delta9-tetrahydrocannabinol in rat brain. Biochemical Pharmacology 23: 873–877, 1974
Colowick SP, Womack FC. Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis. Journal of Biological Chemistry 244: 774–777, 1969
Conway P, Valentovic M, Bachmann K. Tissue binding of warfarin. Research Communications in Chemical Pathology and Pharmacology 26: 309–315, 1979
Cotman C, Brown DH, Harrell BW, Anderson NG. Analytical differential centrifugation: an analysis of the sedimentation properties of synaptosomes, mitochondria and lysosomes from rat brain homogenates. Archives of Biochemistry and Biophysics 136: 436–447, 1970
Damm KH, Erttmann RR, Hoene R. Species differences in plasma binding and tissue uptake of 3H-digitoxin. Naunyn-Schmiedebergs Archives of Pharmacology 291: 371–383, 1975
Danon A, Chen Z. Binding of imipramine to plasma proteins: effect of hyperlipoproteinemia. Clinical Pharmacology and Therapeutics 25: 316–321, 1979
D’Arcy PF, McElnay JC. Drug interactions involving the displacement of drugs from plasma protein and tissue binding site. Pharmacology and Therapeutics 17: 211–220, 1982
Davis ME, Mehendale HM. Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung. Drug Metabolism and Disposition 7: 425–428, 1979
Davison C. Protein binding. In La Du, et al. (Eds) Fundamentals of drug metabolism and disposition, Williams & Wilkins Company, Baltimore (1971)
Di Salle E, Pacifici GM, Morselli PL. Studies on plasma protein binding of carbamazepine. Pharmacological Research Communications 6: 193–202, 1974
Dollery CT, Junod AF. Concentration of (±)-propranolol in isolated, perfused lungs of rat. British Journal of Pharmacology 57: 67–71, 1976
Drew G, Nicholls PJ. The concentration of basic and acidic compounds in guinea-pig lung. Journal of Pharmacy and Pharmacology 28: 84P, 1976
Dromgoole SH. The effect of haemodialysis on the binding capacity of albumin. Clinica Chimica Acta 46: 469–472, 1973
Dutta S, Goswami S, Lindower JO, Marks BH. Subcellular distribution of digoxin-H3 in isolated guinea-pig and rat hearts. Journal of Pharmacology and Experimental Therapeutics 159: 324–334, 1968
Dutta S, Marks BH, Stephen PM. The uptake and subcellular distribution of radio-labelled metabolites of digitoxin in the guinea-pig isolated perfused heart. British Journal of Pharmacology 56: 437–441, 1976
Eap CB, Cuendet C, Baumann P. Binding of D-methadone, L-methadone, and DL-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha-1-acid glycoprotein. Clinical Pharmacology and Therapeutics 47: 338–346, 1990
Ehrnebo M, Agurell S, Jailing B, Boreus LO. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. European Journal of Clinical Pharmacology 3: 189–193, 1971
Ekman B, Sjoholm I. Improved stability of proteins immobilized in microparticles prepared by a modified emulsion polymerization technique. Journal of Pharmaceutical Sciences 67: 693–696, 1978
Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA. Stereoselective plasma protein binding of ibuprofen enantiomers. European Journal of Clinical Pharmacology 36: 283–290, 1989
Evans G, Wilkinson GR, Shand DG. The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver. Journal of Pharmacology and Experimental Therapeutics 186: 447–454, 1973
Feely J, Stevenson IH, Crooks J. Altered plasma protein binding of drugs in thyroid disease. Clinical Pharmacokinetics 6: 298–305, 1981
Feldman HA. Mathematical theory of complex ligand-binding system at equilibrium. Analytical Biochemistry 48: 317–338, 1972
Fichtl B, Bondy B, Kurz H. Binding of drugs to muscle tissue: dependence on drug concentration and lipid content of tissue. Journal of Pharmacology and Experimental Therapeutics 215: 248–253, 1980
Fichtl B, Kurz H. Binding of drugs to human muscle. European Journal of Clinical Pharmacology 14: 335–340, 1978
Fichtl B, Nieciecki AV, Walter K. Tissue binding versus plasma binding of drugs: general principles and pharmacokinetic consequences. Advances in Drug Research 20: 117–166, 1991
Fremstad D, Jacobsen S. Binding of quinidine in serum and heart from normal and anuric rats, and the significance for distribution. Biochemical Pharmacology 28: 2611–2616, 1979
Furlong CE, Morris RG, Kandrach M, Rosen BP. A multichamber equilibrium dialysis apparatus. Analytical Biochemistry 47: 514–526, 1972
Gardiner TH, Lewis JM, Shore PA. Distribution of clozapine in the rat: localization in lung. Journal of Pharmacology and Therapeutics 206: 151–157, 1978
Gibaldi M, McNamara PJ. Tissue binding of drugs. Journal of Pharmaceutical Sciences 66: 1211–1212, 1977
Gillette JR. The importance of tissue distribution in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1: 497–520, 1973
Goldbaum LR, Smith PK. The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions. Journal of Pharmacology and Experimental Therapeutics 111: 197–209, 1954
Goldberg MA, Todoroff T. Enhancement of diphenylhydantoin binding by lipid extraction. Journal of Pharmacology and Experimental Therapeutics 196: 579–585, 1976
Gross AS, Heuer B, Eichelbaum M. Stereoselective protein binding of verapamil enantiomers. Biochemical Pharmacology 37: 4623–4627, 1988
Gugler R, Azarnoff DL. Drug protein binding and the nephrotic syndrome. Clinical Pharmacokinetics 1: 25–35, 1976
Hamar C, Levy G. Serum protein binding of drugs and bilirubin in newborn infants and their mother. Clinical Pharmacology and Therapeutics 28: 58–63, 1980
Harashima H, Sugiyama Y, Sawada Y, Iga T, Hanano M. Comparison between in-vivo and in-vitro tissue-to-plasma unbound concentration ratios (Kp,f) of quinidine in rats. Journal of Pharmacy and Pharmacology 36: 340–342, 1984
Henderson SJ, Lindup WE. Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding of uraemia, with human albumin. Biochemical Pharmacology 40: 2543–2548, 1990
Hesketh TR, Doré CF. A technique for miniature dialysis. Analytical Biochemistry 49: 298–300, 1972
Hill MD, Abramson FP. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clinical Pharmacokinetics 14: 156–170, 1988
Hollt V, Teschemacher HJ. Hydrophobic interactions responsible for unspecific binding of morphine-like drugs. Naunyn-Schmiedebergs Archives of Pharmacology 288: 163–177, 1975
Holmgren A, Luthman M. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry 17: 4071–4077, 1978
Hooper WD, Bochner F, Mervyn JE, Tyrer JH. Plasma protein binding of diphenylhydantoin — effects of sex hormones, renal and hepatic disease. Clinical Pharmacology and Therapeutics 15: 276–282, 1973
Hori R, Okumura K, Yoshida H. Binding of basic drugs to rat lung mitochondria. Pharmacological Research 4: 142–146, 1987
Hummel JP, Dreyer WJ. Measurement of protein binding phenomena by gel filtration. Biochimica et Biophysica Acta 63: 530–532, 1962
Igari Y, Sugiyama Y, Awazu S, Hanano M. Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat. Journal of Pharmacokinetics and Biopharmaceutics 10: 53–75, 1982
Jung D, Mayersohn M, Perrier D. The ‘ultra-free’ ultrafiltration technique compare with equilibrium dialysis for determination of unbound thiopental concentrations in serum. Clinical Chemistry 27: 166–168, 1981
Junod AF. Accumulation of 14C-imipramine in isolated perfused rat lungs. Journal of Pharmacology and Therapeutics 183: 182–187, 1972
Jusko WJ, Chiang ST. Distribution volume related to body weight and protein binding. American Pharmaceutical Association 71: 469–470, 1982
Jusko WJ, Gretch M. Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metabolism Reviews 5: 43–140, 1976
Kallav Z, Trnovec T, Kettner M, Macickova T, Navarova J, et al. Kinetics of gentamicin accumulation in subcellular structures of the mouse kidney. Journal of Pharmacy and Pharmacology 34: 276–277, 1982
Kasper CB. Isolation and properties of the nuclear envelope. In Fleischer et al. (Eds) Methods in enzymology 31 biomembranes, pp. 279–292, Academic Press, Network, San Francisco, London 1974
Kay RR, Johnston IR. Rapid isolation of nuclear envelopes from rat liver. In Prescott (Ed) Methods in cell biology, Vol. 15 pp. 277–287, Academic Press, New York, San Francisco, London, 1977
Keresztes-Nagy S, Mais RF, Oester YT, Zaroslinski JF. Protein binding methodology: comparison of equilibrium dialysis and frontal analysis chromatography in the study of salicylate binding. Analytical Biochemistry 48: 80–89, 1972
Khalafallah N, Jusko WJ. Determination and prediction of tissue binding of prednisolone in the rabbit. Journal of Pharmaceutical Sciences 73: 362–365, 1984
Klotz IM, Hunston DL. Properties of graphical representations of multiple class of binding sites. Biochemistry 10: 3065–3069, 1971
Klotz IM, Walker M, Pivan RB. The binding of organic ions by proteins. Journal of the American Chemical Society 68: 1486–1490, 1946
Kober A, Ekman B, Sjoholm I. Direct and indirect determination of binding constants of drug-protein complexes with micro-particles. Journal of Pharmaceutical Sciences 67: 107–109, 1978
Kober A, Olsson Y, Sjoholm I. Binding of drugs to human serum albumin XIV: the theoretical basis for the interaction between phenytoin and valproate. Molecular Pharmacology 18: 237–242, 1980
Kornhauser DM, Vestal RE, Shand DG. Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage. Pharmacology 20: 275–283, 1980
Krasner J, Yaffe SJ. Drug-protein binding in the neonate. In Morselli et al. (Eds) Basic and therapeutic aspects of perinatal pharmacology, Raven Press, New York, 1975
Kunin CM. Binding of antibiotics to tissue homogenates. Journal of Infectious Diseases 121: 55–64, 1970
Kuntzman R, Tsai I, Burns JJ. Importance of tissue and plasma binding in determining the retention of norchlorcyclizine and norcyclizine in man dog and rat. Journal of Pharmacology and Experimental Therapeutics 158: 332–339, 1967
Kurz H, Fichtl B. Binding of drugs to tissues. Drug Metabolism Reviews 14: 467–510, 1983
Laduron P. Tissue fractionation in neurobiochemistry: an analytical tool or a source of artifacts. International Review of Neurobiology 20: 251–281, 1977
Laduron P, Leysen J. Specific in vivo binding of neuroleptic drugs in rat brain. Biochemical Pharmacology 26: 1003–1007, 1977
Lawson KJ, Danpure CJ, Fyfe DA. The uptake and subcellular distribution of gold in rat liver cells after in vivo administration of sodium aurothiomalate. Biochemical Pharmacology 26: 2417–2426, 1977
Levy G, Procknal JA, Garrettson LK. Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium. Clinical Pharmacology and Therapeutics 18: 210–214, 1975
Lin JH, Sugiyama Y, Awazu S, Hanano M. In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics 10: 637–647, 1982
Lindup WE. Methods for the measurement of drug binding to plasma proteins. In Rietbrock et al. (Eds) Methods in clinical pharmacology, chapter 9, pp. 267–273, Braunschweig, Wiesbaden, 1980
Lindup WE. Plasma protein binding of drugs some basic and clinical aspects. In Bridges et al. (Eds) Progress in drug metabolism, Vol. 10, pp. 141–185, Taylor & Francis Ltd, London, 1987
Lindup WE, Bishop KA, Collier R. Drug binding defect of uraemic plasma: contribution of endogenous binding inhibitors. In Tillement & Lindenlaub (Eds) Protein binding and drug transport, pp. 397–414, FK Schattauer Verlag, Stuttgart, New York, 1986
Lindup WE, Henderson SJ, Barker CE. Drug binding in renal disease. In Belpaire et al. (Eds) Plasma binding of drugs and its consequences, pp. 103–120, Academia Press, Ghent, 1991
Lima JJ, Jungbluth GL, Devine T, Robertson LW. Stereoselective binding of disopyramide to human plasma protein. Life Sciences 35: 835–839, 1984
Ludden TM, Schanker LS, Lanman RC. Binding of organic compounds to rat liver and lung. Drug Metabolism and Disposition 4: 8–16, 1976
Lunde KM, Rane A, Yaffe SJ, Lund L, Sjoqvist F. Plasma protein binding of diphenylhydantoin. Clinical Pharmacology and Therapeutics 11: 846–855, 1970
MacKichan JJ. Pharmacokinetic consequences of drug displacement from blood and tissue proteins. Clinical Pharmacokinetics 9 (Suppl. 1): 32–41, 1984
Manara L. Brain cellular distribution of in vivo administered drugs. In Tillement (Ed) Advances in pharmacology and therapeutics, biochemical clinical pharmacology Vol. 7, pp. 187–199, Pergamon Press, Oxford, New York, 1978
Manara L, Mennini T, Cerletti C. [3H]-Reserpine persistently bound ‘in vivo’ to rat brain subcellular components: limited removal by peanut oil extraction. Life Sciences 14: 2267–2276, 1974
Manara L, Serra G. Drug distribution in the brain. In Deniker et al. (Eds) Neuro-psychopharmacology, pp. 831–840, Pergamon Press, Oxford, New York, 1978
Martin BK. Potential effects of the plasma proteins on drug distribution. Nature 207: 274–276, 1965
Marzo A, Ghirardi P, Preti A, Lombardo A, Longhini C, et al. Subcellular distribution of deslanatoside C, ouabain and digitoxin in the heart and liver of conscious guinea pigs. Biochemical Pharmacology 26: 2427–2443, 1972
McArthur JN, Dawkins PD, Smith MJH. The relation between circulating and tissue concentrations of salicylate in the mouse in vivo. Journal of Pharmacy and Pharmacology 22: 801–805, 1970
McTigue JJ, Henderson SJ, Lindup WE. Excretion of the uraemic metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human urine. Nephron 55: 214–215, 1990
Minchin RF, Ilett KF. Comparative uptake of quinine and quinidine in rat lung. Journal of Pharmacy and Pharmacology 33: 464–466, 1981
Morselli PL, Franco-Morselli R, Bossi L. Clinical Pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clinical Pharmacokinetics 5: 485–527, 1980
Muller W, Wollert U. Characterization of the binding of benzodiazepines to human serum albumin. Naunyn-Schmiedebergs Archives of Pharmacology 280: 229–237, 1973a
Muller W, Wollert U. Influence of pH on the benzodiazepinehuman serum albumin complex. Naunyn-Schmiedebergs Archives of Pharmacology 283: 67–82, 1974
Muller W, Wollert U. Interactions of benzodiazepines with human serum albumin. Naunyn-Schmiedebergs Archives of Pharmacology 278: 301–312, 1973b
Muller WE, Wollert U. Interaction of benzodiazepine derivatives with bovine serum albumin-1. Biochemical Pharmacology 25: 141–145, 1976a
Muller WE, Wollert U. Interaction of benzodiazepine derivatives with bovine serum albumin-II. Biochemical Pharmacology 25: 147–152, 1976b
Nau H, Luck W, Kuhnz W. Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels. British Journal of Clinical Pharmacology 17: 92–98, 1984
Ng DS, Maickel RP, Borowitz JL. Subcellular distribution of weak acids and bases in adrenal medulla. General Pharmacology 13: 15–20, 1982
Nilsson KB, Andersson RGG, Enestrom S, Mackerlova L, Mohme-Lundholm E. Biochemical and morphological characterization of subcellular fractions isolated from rabbit colon muscle. Acta Pharmacologica et Toxicologica 42: 194–205, 1978
Noack E, Cawello W, Bonn R. Kinetic studies of the tissue binding tendency of the new vasodilator pildralazine. Arzneimittel-Forschung 37: 407–409, 1987
Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clinical Pharmacokinetics 18: 20–36, 1990
Ofori-Adjei D, Ericsson O, Lindstrom B, Sjoqvist F. Protein binding of chloroquine enantiomers and desethylchloroquine. British Journal of Clinical Pharmacology 22: 356–358, 1986
Ohmiya Y, Mehendale HM. Uptake and metabolism of chlorpromazine by rat and rabbit lungs. Drug Metabolism and Disposition 8: 313–318, 1980
Oie S, Tozer TN. Effect of altered plasma protein binding on apparent volume of distribution. American Pharmaceutical Association 68: 1203–1205, 1979
Okudaira K, Sawada Y, Sugiyama Y, Iga T, Hanano M. Effect of quinidine on the tissue binding of digoxin in guinea-pigs. Journal of Pharmacy and Pharmacology 38: 137–140, 1986
Oravcova J, Bystricky S, Trnovec T. Different binding of propranolol enantiomers to human alpha-1-acid glycoprotein. Biochemical Pharmacology 38: 2575–2579, 1989
Oravcova J, Lindner W, Szalay P, Bohacik L, Trnovec T. Interaction of propafenone enantiomers with human alpha-1-acid glycoprotein. Chirality 3: 30–34, 1991a
Oravcova J, Mlynarik V, Bystricky S, Soltes L, Szalay P, et al. Interaction of pirprofen enantiomers with human serum albumin. Chirality 3: 412–417, 1991b
Orton TC, Anderson MW, Pickett RD, Eling TE, Fouts JR. Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs. Journal of Pharmacology and Experimental Therapeutics 186: 482–497, 1973
Pacifici GM, Colizzi C, Giuliani L, Rane A. Nuclear epoxide hydrolase in the human fetal and adult liver. Pharmacology 28: 321–328, 1984b
Pacifici GM, Cuoci L, Placidi GF. Subcellular distribution of pinazepam and its metabolite N-desmethyldiazepam in rat liver. General Pharmacology 15: 353–355, 1984c
Pacifici GM, Cuoci L, Rane A. Subcellular distribution of styrene oxide in rat liver. Toxicologic Pathology 12: 69–73, 1984d
Pacifici GM, Taddeucci-Brunelli G, Rane A. Clonazepam serum protein binding during development. Clinical Pharmacology Therapeutics 3: 354–359, 1984a
Pacifici GM, Viani A, Schulz H-U, Frercks H-J. Plasma protein binding of furosemide in the elderly. European Journal of Clinical Pharmacology 32: 199–202, 1987c
Pacifici GM, Viani A, Taddeucci-Brunelli. Serum protein binding of furosemide in new born infants and children. Development of Pharmacology and Therapeutics 10: 413–421, 1987a
Pacifici GM, Viani A, Taddeucci-Brunelli G, Rizzo G, Carrai M, et al. Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alfa-1-acid glycoprotein: implications for binding of drugs. Therapeutic Drug Monitoring 8: 259–263, 1986
Pacifici GM, Viani A, Taddeucci-Brunelli G, Rizzo G, Carrai M. Plasma protein binding of dicloxocillin: effects of age and diseases. International Journal of Clinical Pharmacology Therapy and Toxicology 25: 622–626, 1987b
Paulus H. A rapid and sensitive method for measuring the binding of radioactive ligands to proteins. Analytical Biochemistry 32: 91–100, 1969
Pawlak JW, Konopa J. In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3′) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells. Biochemical Pharmacology 28: 3391–3402, 1979
Pedersen LE, Bonde J, Graudal NA, Backer NV, Hansen JES. Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function. British Journal of Clinical Pharmacology 23: 41–46, 1987
Perucca E, Crema A. Plasma protein binding of drugs in pregnancy. Clinical Pharmacokinetics 7: 336–352, 1982
Peterson LR, Gerding DN, McLinn D, Hall WH. Prediction of peak penicillin and cephalosporin concentrations in canine serum as derived from in vitro serum and tissue quantitative protein binding. Journal of Antimicrobial Chemotherapy 5: 219–227, 1979
Piafsky KM. Disease-induced changes in the plasma binding of basic drugs. Clinical Pharmacokinetics 5: 246–262, 1980
Piafsky KM, Borga O, Odar-CederIof I, Johansson C, Sjoqvist F. Increased plasma protein binding of propranolol and chlor-promazine mediated by disease induced elevation of plasma alpha-1-acid glycoprotein. New England Journal of Medicine 299: 1435–1439, 1978
Post C. Studies on the pharmacokinetic function of the lung with special reference to lidocaine. Acta Pharmacologica et Toxicologica 44 (Suppl. 1): 7–53, 1979
Powis G, Melder DC, Wilke TJ. Human and dog, but not rat, isolated hepatocytes have decreased foreign compound-metabolizing activity compared to liver slices. Drug Metabolism and Disposition 17: 526–531, 1989
Powis G, Moore DJ, Wilke TJ, Santone KS. A high-performance liquid chromatography assay for measuring integrated biphenyl metabolism by intact cells: its use with rat liver and human liver and kidney. Analytical Biochemistry 167: 191–198, 1987
Prandota J, Pruitt AW. Furosemide binding to human albumin and plasma of nephrotic children. Clinical Pharmacology and Therapeutics 17: 159–166, 1975
Rane A, Wilson JT. Clinical pharmacokinetics in infants and children. Clinical Pharmacokinetics 1: 2–24, 1976
Rehavi M, Skolnick P, Paul SM. Subcellular distribution of high affinity [3H]serotonin uptake in rat brain. European Journal of Pharmacology 87: 335–339, 1983
Rehberg PB. A centrifugation method of ultrafiltration using cellophane tubes. Acta Physiologica Scandinavica 5: 115–126, 1943
Reidenberg MM. Effect of disease states on plasma protein binding of drugs. Medical Clinics of North America 58: 1103–1109, 1974
Reidenberg MM. The binding of drugs to plasma proteins from patients with poor renal function. Clinical Pharmacokinetics 1: 121–125, 1976
Reidenberg MM, Drayer DE. Alteration of drug-protein binding in renal disease. Clinical Pharmacokinetics 9 (Suppl. 1): 18–26, 1984
Rolinson GN, Sutherland R. The binding of antibiotics to serum proteins. British Journal of Pharmacology 25: 638–650, 1965
Rolleri E, Hegesippe M. Use of serum albumin michrospheres as a reversible adsorbent for studying protein-small molecule interactions. Bichimica et Biophysica Acta 295: 429–437, 1973
Roosdorp N, Wann B, Sjoholm I. Correlation between arginyl residue modification and benzodiazepine binding to human serum albumin. Journal of Biological Chemistry 252: 3876–3880, 1977
Rosenthal AE. A graphic method for the determination and presentation of binding parameters in a complex system. Analytical Biochemistry 20: 525–532, 1967
Routledge PA, Barchowsky A, Bjorsson TD, Kitchell BB, Shand DG. Lidocaine plasma protein binding. Clinical Pharmacology and Therapeutics 27: 347–351, 1980
Rowland M. Protein binding and drug clearance. Clinical Pharmacokinetics 9 (Suppl. 1): 10–17, 1984
Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications, Lea & Febiger, Philadelphia, 1980
Salzman NP, Brodie BB. Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 118: 46–54, 1956
Scatchard G. The attractions of proteins for small molecules and ions. New York Academy of Science 51: 660–692, 1949
Schanker LS, Morrison AS. Physiological disposition of guanethidine in the rat and its uptake by heart slices. Journal of Neuropharmacology 4: 27–39, 1965
Schiff D, Chan G, Stern L. Sephadex G-25 quantitative estimation of free bilirubin potential in jaundiced newborn infants’ sera: a guide to the prevention of kernicterus. Journal of Laboratory and Clinical Medicine 80: 455–462, 1972
Schmidt W, Jahnchen E. Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats. Journal of Pharmacokinetics and Biopharmaceutics 7: 643–663, 1979
Schneck DW, Pritchard JF, Hayes AH. Studies on the uptake and binding of propranolol by rat tissues. Journal of Pharmacology and Experimental Therapeutics 203: 621–629, 1977
Shand DG, Branch RA, Evans GH, Nies AS, Wilkinson GR. The disposition of propranolol VII: the effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver. Drug Metabolism and Disposition 1: 679–686, 1973
Shum L, Jusko WJ. Theophylline tissue partitioning and volume of distribution in normal and dietary-induced obese rats. Bio-pharmaceutics and Drug Disposition 8: 353–364, 1987
Siddik ZH, Drew R, Gram TE. The effect of chlorpromazine on the uptake and efflux of paraquat in rat lung slices. Toxicology and Applied Pharmacology 50: 443–450, 1979
Sjodin T, Roosdorp N, Sjoholm I. Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements. Biochemical Pharmacology 25: 2131–2140, 1976
Sjoholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Seiving B, et al. Binding of drugs to human serum albumin XI. Molecular Pharmacology 16: 767–777, 1979
Sjoqvist F. Therapeutic drug monitoring — twenty years’ experience. In Lemberger & Reidenberg (Eds) Proceedings of the Second World Conference on Clinical Pharmacology and Therapeutics, pp. 38–63, American Society for Pharmacology and Experimental Therapeutics, Bethesda, 1984
Storstein L. Protein binding of cardiac glycosides in disease states. Clinical Pharmacokinetics 2: 220–233, 1977
Street JA, Gonda I, Parkinson H, Hemsworth BA. Lung accumulation of some β-adrenoceptor antagonists. Journal of Pharmacy and Pharmacology 30: 56P, 1978
Tesseromatis C, Fichtl B, Kurz H. Binding of non-steroid antiinflammatory drugs and warfarin to liver tissue of rabbits in vitro. European Journal of Drug Metabolism and Pharmacokinetics 12: 161–167, 1987
Tillement JP, Houin G, Zini R, Urien S, Albengres E, et al. The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance. In Advances in drug research, pp. 59–94, Academic Press, London, 1984
Tillement JP, Lhoste F, Giudicelli JF. Diseases and drug protein binding. Clinical Pharmacokinetics 3: 144–154, 1978
Tiula E. A pressure ultrafiltration method for serum free drug determination: comparison with equilibrium dialysis using normal and uraemic sera. Methods and Findings in Experimental and Clinical Pharmacology 6: 51–55, 1984
Trenk D, Jahnchen E. Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats. Journal of Pharmacokinetics and Biopharmaceutics 8: 177–191, 1980
Van Peer AP, Belpaire FM, Bogaert MG. Binding of drugs in serum, blood cells and tissues of rabbits with experimental acute renal failure. Pharmacology 22: 146–152, 1981
Veering BTH, Burm AGL, Souverijn JHM, Serree JMP, Spierdijk JOH. The effect of age on serum concentrations of albumin and alfa-1-acid glycoprotein. British Journal of Clinical Pharmacology 29: 201–206, 1990
Verbeeck RK, Cardinal J-A. Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and pethidine using equilibrium dialysis and ultracentrifugation. Arzneimittel-Forschung 35: 903–906, 1985
Verbeeck RK, Cardinal JA, Wallace SM. Effects of age and sex on the plasma binding of acidic and basic drugs. European Journal of Clinical Pharmacology 27: 91–94, 1984
Viani A, Cappiello M, Pacifici GM. Binding of diazepam salicylic acid and digitoxin to albumin isolated from fetal and adult serum. Developmental Pharmacology and Therapeutics 17: 100–108, 1991b
Viani A, Cappiello M, Silvestri D, Pacifici GM. Binding of furosemide to albumin isolated from human fetal and adult serum. Developmental Pharmacology and Therapeutics 16: 33–40, 1991a
Viani A, Pacifici GM. Bilirubin displaces furosemide from serum protein: the effect is greater in newborn infants than adult subjects Developmental Pharmacology Therapeutics 14: 90–95, 1990
Viani A, Rizzo G, Carrai M, Pacifici GM. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in newborns, healthy subjects and patients with renal or liver disease: implications for binding of drugs. International Journal Clinical Pharmacology Therapeutic and Toxicology, 30: 128–133, 1992a
Viani A, Rizzo G, Carrai M, Pacifici GM. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. British Journal of Clinical Pharmacology, 33: 299–304, 1992b
Wallace S, Whiting B. Factors affecting drug binding in plasma of elderly patients. British Journal of Clinical Pharmacology 3: 327–330, 1976
Wallace SM, Verbeeck RK. Plasma protein binding of drugs in the elderly. Clinical Pharmacokinetics 12: 41–72, 1987
Wallach DFH, Schmidt-Ullrich R. Isolation of plasma membrane vesicles from animal cells. In Prescott (Ed.) Methods in cell biology pp 235–276, Academic Press, New York, San Francisco, London, 1977
Walter K, Kurz H. Binding of drugs to human skin:influencing factors and the role of tissue lipids. Journal of Pharmacy and Pharmacology 40: 689–693, 1988
Weder HG, Schildknecht J, Kesselring P. A new equilibrium dialyzing system. American Laboratory 10: 15–21, 1971
Wibo M, Thines-Sempoux D, Amar-Costesec A, Beaufay H, Godelaine D. Analytical study of microsomes and isolated subcellular membranes from rat liver VIII: subfractionation of preparation enriched with plasma membranes, outer mitochondrial membranes, or Golgi complex membranes. Journal of Cell Biology 89: 456–474, 1981
Wilkinson GR. Clearance approaches in pharmacology. Pharmacological Reviews 39: 1–47, 1987
Wilkinson GR. Plasma and tissue binding considerations in drug disposition. Drug Metabolism Review 14: 427–465, 1983
Williams LT, Lefkowitz RJ. Reception Binding Studies in Adrenergic Pharmacology, Raven Press, New York (1978)
Wilson AGE, Law FCP, Eling TE, Anderson MW. Uptake, metabolism and efflux of methadone in ‘single pass’ isolated perfused rabbit lungs. Journal of Pharmacology and Experimental Therapeutics 199: 360–367, 1976
Wilting J, Weideman MM, Roomer ACJ, Perrin JH. Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements. Biochimica et Biophysica Acta 579: 469–473, 1979
Windorfer A, Karitzky D, Gasteiger U, Stehr K. Investigations on salicylate protein binding in newborns and infants. European Journal Pediatrics 127: 163–172, 1978
Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clinical Pharmacokinetics 11: 470–482, 1986
Wittfoht W, Duwe K, Kuhnz W, Nau H. Microscale ultrafiltration technique for determining free drug in 50µl serum samples. Clinical Chemistry 30: 878–879, 1984
Wosilait WD. The accumulation and distribution of dicoumarol in rat liver slices. Biochemical Pharmacology 17: 429–437, 1968
Yu HY, Sawada Y, Sugiyama Y, Iga T, Hanano M. Effect of sulphadimethoxine on thiopental distribution and elimination in rats. American Pharmaceutical Association 70: 323–326, 1981
Zaroslinski JF, Keresztes-Nagy S, Mais RF, Oester YT. Effect of temperature on the binding of salicylate by human serum albumin. Biochemical Pharmacology 23: 1767–1776, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pacifici, G.M., Viani, A. Methods of Determining Plasma and Tissue Binding of Drugs. Clin. Pharmacokinet. 23, 449–468 (1992). https://doi.org/10.2165/00003088-199223060-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199223060-00005